loader from loading.io

Why this endo is pushing for a diabetes drug you've probably never heard of (and the FDA has rejected).

Diabetes Connections | Type 1 Diabetes

Release Date: 08/26/2025

Finding Diabetes Joy: How Poetry Helped Ephraim Navigate a T1D Diagnosis show art Finding Diabetes Joy: How Poetry Helped Ephraim Navigate a T1D Diagnosis

Diabetes Connections | Type 1 Diabetes

In this bonus episode of Diabetes Connections, meet Ephraim Sommers, an English professor and poet diagnosed with LADA (a slower-developing form of type 1 diabetes) in his early 40s. Even though his father has type 1, Ephraim wasn't prepared for the fear, anxiety, and mental load of managing diabetes himself. So he turned to poetry. Every weekday, he sat in a coffee shop and wrote about gratitude. Those poems became about finding joy while living with diabetes. We talk about shifting from fear to gratitude, advocating for yourself, and why poetry might help even if you haven't read a poem...

info_outline
Can a 100-Old Vaccine Impact Type 1 Diabetes?  A Conversation with Dr. Denise Faustman show art Can a 100-Old Vaccine Impact Type 1 Diabetes? A Conversation with Dr. Denise Faustman

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections - looking into a very old vaccine to get new results for people with type 1. Dr. Denise Faustman’s research into the BCG vaccine has been making headlines for a long time, and she's now sharing new results from her clinical trials, including some pretty remarkable claims about A1C, insulin use, and time in range. Now, I know some of you may be surprised that I'm having Dr. Faustman on the show. She's a very controversial figure in the diabetes research world, and her work has sparked plenty of debate and skepticism over the years. We're not ignoring any of...

info_outline
In the News... CGM Coverage, Why A1C vs GMI Matters, Fully Implantable CGM Trialed, T1D at the NYC Marathon and more show art In the News... CGM Coverage, Why A1C vs GMI Matters, Fully Implantable CGM Trialed, T1D at the NYC Marathon and more

Diabetes Connections | Type 1 Diabetes

  This week on Diabetes Connections In the News… big insurance changes could affect your CGM coverage, a new study looks at why the difference between estimated A1C from CGM and the A1C from the lab could really matter to your health, Eversense CGM starts testing a new version that’s completely below the skin, news about heart health and type 1, the next generation of weight loss drug and a big week for sports on the highest level with type 1. And it’s diabetes awareness momth! It’s all coming up right after this. (AD BREAK) Welcome! I’m your host Stacey Simms and this is...

info_outline
What We Learned at the Very First Breakthrough T1D Clinical & Research Congress, with Anastasia Albanese-O'Neill show art What We Learned at the Very First Breakthrough T1D Clinical & Research Congress, with Anastasia Albanese-O'Neill

Diabetes Connections | Type 1 Diabetes

What happened at the very first Breakthrough T1D Clinical and Research Congress? More than a thousand people from 33 countries came together to talk about everything from islet cell transplants and new treatments to screening, prevention, and the growing role of GLP-1 medications in type 1 diabetes. I’m talking to Anastasia Albanese-O'Neill, vice president, medical affairs for Breakthrough, who joins us fresh off the conference to share the biggest headlines, what she's most excited about, and why she says we're at an inflection point in type 1 diabetes care. We also talk about how even the...

info_outline
Meet GLUKI, the T1D App Helping Kids Learn Through Play show art Meet GLUKI, the T1D App Helping Kids Learn Through Play

Diabetes Connections | Type 1 Diabetes

On this bonus episode of diabetes connections.. the creator o designed to help kids understand diabetes through games, rewards, and interactive learning. I’m talking to Staci DePatie who lives with type 1.  Staci's working with students at UC Irvine to bring Gluki to life, including some interesting new AI features. We'll talk about how it all works, why she believes building what she calls "diabetes IQ" is so important, and I'll ask some questions about AI safety, cost, and whether kids really want to spend more time thinking about diabetes, even if it’s as part of a game. This...

info_outline
In the News.. Dexcom controversy, New T1D research, and a World Series moment to remember! show art In the News.. Dexcom controversy, New T1D research, and a World Series moment to remember!

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections In the News… a change from Dexcom sparks a big community response  New developments in the race to protect insulin-producing beta cells, Lilly's GLP-1 pill moves closer to approval in Europe, and could remote monitoring help kids with type 1 improve their glucose management? Plus, are pregnant women being left behind by automated insulin delivery technology? And a Major League moment to remember as a player with type 1 diabetes sends the Milwaukee Brewers to the World Series! Check out all of Announcing Community Commericals! Learn how to  Learn...

info_outline
Sernova + Seraxis: A New Partnership in the  Race for a T1D Cure with CEOs  Johnathan Rigby and Dr. Will Rust show art Sernova + Seraxis: A New Partnership in the Race for a T1D Cure with CEOs Johnathan Rigby and Dr. Will Rust

Diabetes Connections | Type 1 Diabetes

A new company brings together two technologies: lab-grown insulin-producing cells and an implantable pouch designed to help those cells survive and function inside the body. Sernova makes the pouch, Seraxis grows the cells – together they are BetaNova hopes that bringing these two technologies together could move us closer to a functional cure for type 1 diabetes. So what does this merger really mean? What makes these cells different? And could this approach eventually work without immunosuppressive drugs and actually be available to millions of people with type 1? I'm talking with the CEOs...

info_outline
What's Next for Dexcom?  G8, New Research & Your Questions with Jessica Castle, VP Global Medical Affairs show art What's Next for Dexcom? G8, New Research & Your Questions with Jessica Castle, VP Global Medical Affairs

Diabetes Connections | Type 1 Diabetes

On this bonus episode of Diabetes Connections, catching up with Dexcom after the EASD  international conference. I’m asking your questions about longer sensor wear for kids, changes to adhesive, what’s going on with the G8 and more.  Plus Dexcom presented a few studies at the summer conferences about some pretty significant benefits of CGM, including fewer DKA-related hospital visits for people with type 1 and improved glucose outcomes for people with type 2 who aren't using insulin. This podcast is not meant at medical advice, if you have those types of questions, please ask...

info_outline
In the News... Experimental new peptide for T2D, low-carb studies in kids, GLP-1 pill info, gaps in CGM access, fashion line honors a T1D icon, and more! show art In the News... Experimental new peptide for T2D, low-carb studies in kids, GLP-1 pill info, gaps in CGM access, fashion line honors a T1D icon, and more!

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections In the News… A new combination drug shows big weight loss and A1C improvements for people with type 2. New guidance aims to cut down on adults being misdiagnosed with the wrong type of diabetes. Could trying to keep your glucose too steady affect your quality of life? Very low-carb diets for kids with type 1, and new research on putting early-onset type 2 into remission. The FDA clears an app that recommends insulin dose changes directly to people using injections—and approves a once-a-week insulin for type 2. Plus, new data on Lilly’s daily GLP-1...

info_outline
Moving Diabetes Solutions Forward:  Beyond Type 1’s Innovation Accelerator show art Moving Diabetes Solutions Forward: Beyond Type 1’s Innovation Accelerator

Diabetes Connections | Type 1 Diabetes

On this bonus episode of diabetes connections, we’re talking about the Beyond Barriers Innovation Accelerator. This is a project from Beyond Type 1 which is investing in community-based organizations and entrepreneurs working to close those gaps. We’ll hear about some really interesting projects from comic books for kids to apps for first responders and programs to help with cost… And we’ll zoom out: eleven years after Beyond Type 1 launched, what is the organization today—and how is it trying to make sure more people with diabetes have the opportunity not just to survive, but to...

info_outline
 
More Episodes

We've got an important update on a diabetes drug you may have never heard about. Sotagliflozin is known to have big benefits for people with type 2 but getting it approved for type 1 has been frustrating to say the least.

The FDA has twice declined to approve it for people with T1D, but experts – including my guest – are pushing and hoping that will soon change. I’m talking to Dr. Steve Edleman, an endocrinologist who lives with type 1 and heads up the group Take Control of Your Diabetes – TCOYD.

We’ll talk about the risks that come with sotogliflozin, how continuous ketone monitoring could change the game, and what you can do to push for change. TCOYD's petition here

This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

Join us at an upcoming Moms' Night Out event!

Learn more about studies and research at Thrivable here

Please visit our Sponsors & Partners - they help make the show possible!

Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)

Omnipod - Simplify Life

Learn about Dexcom 

Check out VIVI Cap to protect your insulin from extreme temperatures

The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:

Sign up for our newsletter here

Here's where to find us:

Facebook (Group)

Facebook (Page)

Instagram

Check out Stacey's books!

Learn more about everything at our home page www.diabetes-connections.com 

Reach out with questions or comments: info@diabetes-connections.